Bio-Rad Laboratories (NYSE:BIO.B) Sets New 12-Month High – Here’s What Happened

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price reached a new 52-week high during mid-day trading on Friday . The company traded as high as $357.05 and last traded at $357.05, with a volume of 332 shares trading hands. The stock had previously closed at $348.95.

Bio-Rad Laboratories Stock Performance

The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The firm’s fifty day moving average is $334.78 and its 200 day moving average is $327.19. The company has a market cap of $10.00 billion, a PE ratio of -13.06 and a beta of 0.72.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its earnings results on Wednesday, October 30th. The company reported $2.01 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%. The business had revenue of $649.73 million for the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.